IMRN
Price
$0.81
Change
-$0.03 (-3.57%)
Updated
Feb 4 closing price
Capitalization
7.26M
27 days until earnings call
Intraday BUY SELL Signals
VTGN
Price
$0.53
Change
-$0.01 (-1.85%)
Updated
Feb 4 closing price
Capitalization
20.78M
Intraday BUY SELL Signals
Interact to see
Advertisement

IMRN vs VTGN

Header iconIMRN vs VTGN Comparison
Open Charts IMRN vs VTGNBanner chart's image
Immuron
Price$0.81
Change-$0.03 (-3.57%)
Volume$26.2K
Capitalization7.26M
VistaGen Therapeutics
Price$0.53
Change-$0.01 (-1.85%)
Volume$849.43K
Capitalization20.78M
IMRN vs VTGN Comparison Chart in %
IMRN
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMRN vs. VTGN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a StrongBuy and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (IMRN: $0.81 vs. VTGN: $0.53)
Brand notoriety: IMRN and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 4% vs. VTGN: 25%
Market capitalization -- IMRN: $7.26M vs. VTGN: $20.78M
IMRN [@Biotechnology] is valued at $7.26M. VTGN’s [@Biotechnology] market capitalization is $20.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, IMRN is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • IMRN’s TA Score: 3 bullish, 5 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than IMRN.

Price Growth

IMRN (@Biotechnology) experienced а -16.21% price change this week, while VTGN (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Reported Earning Dates

IMRN is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($20.8M) has a higher market cap than IMRN($7.27M). IMRN YTD gains are higher at: 6.557 vs. VTGN (-20.502). IMRN has higher annual earnings (EBITDA): -7.35M vs. VTGN (-64.79M). VTGN has more cash in the bank: 77.2M vs. IMRN (7.74M). IMRN has higher revenues than VTGN: IMRN (6.54M) vs VTGN (721K).
IMRNVTGNIMRN / VTGN
Capitalization7.27M20.8M35%
EBITDA-7.35M-64.79M11%
Gain YTD6.557-20.502-32%
P/E RatioN/AN/A-
Revenue6.54M721K907%
Total Cash7.74M77.2M10%
Total DebtN/A1.87M-
FUNDAMENTALS RATINGS
IMRN vs VTGN: Fundamental Ratings
IMRN
VTGN
OUTLOOK RATING
1..100
9581
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6597
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (15) in the Biotechnology industry is in the same range as VTGN (15). This means that IMRN’s stock grew similarly to VTGN’s over the last 12 months.

IMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that IMRN’s stock grew similarly to VTGN’s over the last 12 months.

IMRN's SMR Rating (97) in the Biotechnology industry is in the same range as VTGN (98). This means that IMRN’s stock grew similarly to VTGN’s over the last 12 months.

IMRN's Price Growth Rating (65) in the Biotechnology industry is in the same range as VTGN (97). This means that IMRN’s stock grew similarly to VTGN’s over the last 12 months.

IMRN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that IMRN’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMRNVTGN
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
73%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IMRN
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGPS0.830.04
+5.25%
LogProstyle Inc
GHC1160.183.23
+0.28%
Graham Holdings Company
NVCT8.46-0.02
-0.24%
Nuvectis Pharma
SE106.26-1.94
-1.79%
Sea Limited
ORIC10.61-0.39
-3.55%
Oric Pharmaceuticals

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with LABFF. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
-3.43%
LABFF - IMRN
81%
Closely correlated
N/A
VTGN - IMRN
79%
Closely correlated
-3.20%
QNCX - IMRN
77%
Closely correlated
+9.28%
TPST - IMRN
74%
Closely correlated
-1.24%
CALC - IMRN
72%
Closely correlated
+8.37%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been closely correlated with QNCX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTGN jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.20%
QNCX - VTGN
92%
Closely correlated
+9.28%
RZLT - VTGN
87%
Closely correlated
-7.62%
GNTA - VTGN
83%
Closely correlated
-1.27%
IMRN - VTGN
79%
Closely correlated
-3.43%
BDRX - VTGN
79%
Closely correlated
-11.04%
More